Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators. (Q38693445)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

systematic review

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Ichiro Yasue

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Shinji Matsunaga

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Taro Kishi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Kiyoshi Fujita

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

1 January 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Journal of Alzheimer's Disease

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

733-740

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

A review of Parkinson's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

The prevalence of Parkinson's disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Atypical antipsychotics in Parkinson-sensitive populations

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Psychiatric aspects of Parkinson's disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Serotonin 2A receptors and visual hallucinations in Parkinson disease

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

On the discovery and development of pimavanserin: a novel drug candidate for Parkinson's psychosis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

A comparison of the pharmacokinetics of oral and sublingual cyproheptadine

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

5-HT2A receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Association between the use of serotonin receptor 2A-blocking antidepressants and joint disorders

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

5-HT(2A) inverse-agonists for the treatment of insomnia

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Mirtazapine improves visual hallucinations in Parkinson's disease: a case report

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150818

21 January 2018

Identifiers

10.3233/JAD-150818

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

release_l7ovl7s6fffv3b3diqj4twnfoa

1 reference

https://api.fatcat.wiki/v0/release/l7ovl7s6fffv3b3diqj4twnfoa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26757194%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38693445&oldid=1842933540"